WO2012078982A3 - Xzh-5 inhibits constitutive and interleukin-6-induced stat3 phosphorylation in human hepatocellular carcinoma cells - Google Patents
Xzh-5 inhibits constitutive and interleukin-6-induced stat3 phosphorylation in human hepatocellular carcinoma cells Download PDFInfo
- Publication number
- WO2012078982A3 WO2012078982A3 PCT/US2011/064152 US2011064152W WO2012078982A3 WO 2012078982 A3 WO2012078982 A3 WO 2012078982A3 US 2011064152 W US2011064152 W US 2011064152W WO 2012078982 A3 WO2012078982 A3 WO 2012078982A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- xzh
- stat3 phosphorylation
- interleukin
- hepatocellular carcinoma
- carcinoma cells
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06052—Val-amino acid
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4703—Regulators; Modulating activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/70—Mechanisms involved in disease identification
- G01N2800/7023—(Hyper)proliferation
- G01N2800/7028—Cancer
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42134110P | 2010-12-09 | 2010-12-09 | |
US61/421,341 | 2010-12-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012078982A2 WO2012078982A2 (en) | 2012-06-14 |
WO2012078982A3 true WO2012078982A3 (en) | 2012-09-07 |
Family
ID=46207764
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2011/064152 WO2012078982A2 (en) | 2010-12-09 | 2011-12-09 | Xzh-5 inhibits constitutive and interleukin-6-induced stat3 phosphorylation in human hepatocellular carcinoma cells |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2012078982A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012078982A2 (en) * | 2010-12-09 | 2012-06-14 | The Ohio State University | Xzh-5 inhibits constitutive and interleukin-6-induced stat3 phosphorylation in human hepatocellular carcinoma cells |
US11485750B1 (en) | 2019-04-05 | 2022-11-01 | Kymera Therapeutics, Inc. | STAT degraders and uses thereof |
KR102199141B1 (en) * | 2019-05-03 | 2021-01-06 | 사회복지법인 삼성생명공익재단 | Diagnostic biomarker of colorectal cancer using cytokine-induced STAT phosphorylation in peripheral blood immune cells by flow cytometry |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004073650A2 (en) * | 2003-02-20 | 2004-09-02 | University Of South Florida | Peptidomimetic inhibitors of stat3 activity and their medical uses |
US20090069420A1 (en) * | 2006-05-19 | 2009-03-12 | H. Lee Moffitt Cancer Center & Research Institute | Small molecule inhibitors of STAT3 with anti-tumor activity |
WO2009036099A1 (en) * | 2007-09-10 | 2009-03-19 | Boston Biomedical, Inc. | A novel group of stat3 pathway inhibitors and cancer stem cell pathway inhibitors |
WO2012078982A2 (en) * | 2010-12-09 | 2012-06-14 | The Ohio State University | Xzh-5 inhibits constitutive and interleukin-6-induced stat3 phosphorylation in human hepatocellular carcinoma cells |
-
2011
- 2011-12-09 WO PCT/US2011/064152 patent/WO2012078982A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004073650A2 (en) * | 2003-02-20 | 2004-09-02 | University Of South Florida | Peptidomimetic inhibitors of stat3 activity and their medical uses |
US20090069420A1 (en) * | 2006-05-19 | 2009-03-12 | H. Lee Moffitt Cancer Center & Research Institute | Small molecule inhibitors of STAT3 with anti-tumor activity |
WO2009036099A1 (en) * | 2007-09-10 | 2009-03-19 | Boston Biomedical, Inc. | A novel group of stat3 pathway inhibitors and cancer stem cell pathway inhibitors |
WO2012078982A2 (en) * | 2010-12-09 | 2012-06-14 | The Ohio State University | Xzh-5 inhibits constitutive and interleukin-6-induced stat3 phosphorylation in human hepatocellular carcinoma cells |
Non-Patent Citations (1)
Title |
---|
DATABASE PUBCHEM 21 July 2009 (2009-07-21), "2-[[(2-phenylcarbamoylamino)acetyl]amino]acetic acid", retrieved from http://pubchem.ncbi.nlm.nih.gov/summarylsummary.cgi?cid=43354399&loc=eç rcs accession no. 3354399 * |
Also Published As
Publication number | Publication date |
---|---|
WO2012078982A2 (en) | 2012-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1243082B (en) | Use of chimeric antigen receptor-modified t cells to treat cancer | |
WO2011111880A9 (en) | Pharmaceutical composition for treating or preventing diseases caused by the nuclear export of gsk3, including a compound for inhibiting the nuclear export of gsk3 | |
IN2015DN03795A (en) | ||
ZA201208222B (en) | Process including hydrogenolysis of biomass followed by dehydrogenation and aldol condensation to produce alkanes | |
WO2014062720A3 (en) | Methods of treating cancer | |
WO2014080291A3 (en) | Biaryl derivatives as bromodomain inhibitors | |
EP2755646A4 (en) | Methods and compositions for treating, reversing, inhibiting or preventing resistance to antiplatelet therapy | |
MY164356A (en) | Substituted 5-fluoro-1h-pyrazolopyridines and their use | |
IN2014DN09370A (en) | ||
PH12014501639A1 (en) | Pharmaceutical compositions and methods | |
EP2244714A4 (en) | Use of picoplatin and bevacizumab to treat colorectal cancer | |
EP2440221A4 (en) | Composition used to prevent and treat red blood cell coagulation | |
WO2013188813A3 (en) | Novel therapeutics for brain cancer | |
MX2013008192A (en) | Bace-2 inhibitors for the treatment of metabolic disorders. | |
ZA201307425B (en) | Bio-augmentation composition and use thereof for improving efficiency of effluent treatment in hydrocarbon processing plant | |
WO2012038504A3 (en) | Breast cancer therapeutics | |
EP2626071A4 (en) | Applications of arctigenin in formulating medicines for preventing or treating diseases related to red blood cell reduction | |
EP2930254A4 (en) | Stainless steel-clad steel plate having exceptional corrosion resistance to seawater | |
WO2012167028A9 (en) | Compositions and methods for treating cancer and diseases and conditions responsive to cell growth inhibition | |
WO2012125981A3 (en) | Raf kinase inhibitors | |
HK1191557A1 (en) | Composition adipose tissue-derived secretions for use in the topical treatment or prevention of acne | |
WO2012078982A3 (en) | Xzh-5 inhibits constitutive and interleukin-6-induced stat3 phosphorylation in human hepatocellular carcinoma cells | |
WO2012134169A3 (en) | Composition for lung cancer treatment and functional food containing gleditsiae semen extract | |
AP2011005997A0 (en) | Continuous processing reactors and methods of using same. | |
MX2013002261A (en) | Substituted n-phenethyltriazoloneacetamides and use thereof. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11846099 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205N DATED 16/08/2013 ) |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205N DATED 16/08/2013) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11846099 Country of ref document: EP Kind code of ref document: A2 |